首页 > 最新文献

Pediatric Surgery International最新文献

英文 中文
Dissecting the dynamics of cell death pathways in Hirschsprung's disease: a comparative analysis of viable and non-viable cells under proinflammatory conditions. 剖析赫氏肺病细胞死亡途径的动态变化:在促炎症条件下对有活力和无活力细胞的比较分析。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-11-03 DOI: 10.1007/s00383-024-05862-2
Zhongwen Li, Johanna Hagens, Clara Philippi, Hans Christian Schmidt, Lucie Rohwäder, Pauline Schuppert, Laia Pagerols Raluy, Magdalena Trochimiuk, Konrad Reinshagen, Christian Tomuschat

Purpose: The present study explores the dynamics of cell death in Hirschsprung's disease (HSCR) and control (CO) groups under inflammatory stress conditions.

Methods: Using flow cytometry, we analyzed intestinal colonic organoid cultures derived from the ganglionic segment of the HSCR and CO groups. Our analysis focused on the quantification of RIPK1-independent and RIPK1-dependent apoptosis, as well as necroptosis in both viable and non-viable cells under acute and chronic inflammatory stress.

Results: Our findings indicate that HSCR cells are particularly vulnerable to inflammation during acute proinflammatory stress, as evidenced by an increase in dead cells (Zombie +). Under chronic conditions, adaptive changes are observed in both HSCR and CO groups, indicating survival mechanisms. These adaptations are uniquely altered in HSCR, suggesting an impaired response to chronic inflammation. HSCR cells show significantly decreased RIPK1-dependent apoptosis in acute scenarios compared to chronic ones, unlike the CO group, implying varied responses to different inflammatory stresses. In non-viable cells, considerable changes in RIPK1-dependent apoptosis under chronic conditions in HSCR indicate a heightened inflammatory response compared to CO.

Conclusion: This research provides insights into cell death regulation in HSCR under inflammatory stress by using patient-derived organoids, underscoring the complexity of its inflammatory response.

目的:本研究探讨了在炎症应激条件下赫氏腺病(HSCR)组和对照组(CO)细胞死亡的动态变化:我们使用流式细胞术分析了来自 HSCR 组和 CO 组神经节段的肠结肠类器官培养物。我们的分析重点是在急性和慢性炎症应激条件下,有活力和无活力细胞的 RIPK1 依赖性凋亡和 RIPK1 依赖性凋亡以及坏死的定量分析:我们的研究结果表明,HSCR 细胞在急性促炎症应激时特别容易受到炎症的影响,表现为死亡细胞(Zombie +)的增加。在慢性条件下,HSCR 和 CO 组都观察到了适应性变化,这表明了生存机制。这些适应性在 HSCR 中发生了独特的变化,表明其对慢性炎症的反应能力受损。与慢性炎症组不同的是,HSCR 细胞在急性期与慢性期相比,RIPK1 依赖性凋亡明显减少,这意味着对不同炎症压力的反应各不相同。在不能存活的细胞中,与 CO 组相比,HSCR 组在慢性条件下 RIPK1 依赖性凋亡的显著变化表明炎症反应增强:本研究通过使用源自患者的器官组织,深入了解了 HSCR 在炎症应激下的细胞死亡调控,凸显了其炎症反应的复杂性。
{"title":"Dissecting the dynamics of cell death pathways in Hirschsprung's disease: a comparative analysis of viable and non-viable cells under proinflammatory conditions.","authors":"Zhongwen Li, Johanna Hagens, Clara Philippi, Hans Christian Schmidt, Lucie Rohwäder, Pauline Schuppert, Laia Pagerols Raluy, Magdalena Trochimiuk, Konrad Reinshagen, Christian Tomuschat","doi":"10.1007/s00383-024-05862-2","DOIUrl":"10.1007/s00383-024-05862-2","url":null,"abstract":"<p><strong>Purpose: </strong>The present study explores the dynamics of cell death in Hirschsprung's disease (HSCR) and control (CO) groups under inflammatory stress conditions.</p><p><strong>Methods: </strong>Using flow cytometry, we analyzed intestinal colonic organoid cultures derived from the ganglionic segment of the HSCR and CO groups. Our analysis focused on the quantification of RIPK1-independent and RIPK1-dependent apoptosis, as well as necroptosis in both viable and non-viable cells under acute and chronic inflammatory stress.</p><p><strong>Results: </strong>Our findings indicate that HSCR cells are particularly vulnerable to inflammation during acute proinflammatory stress, as evidenced by an increase in dead cells (Zombie +). Under chronic conditions, adaptive changes are observed in both HSCR and CO groups, indicating survival mechanisms. These adaptations are uniquely altered in HSCR, suggesting an impaired response to chronic inflammation. HSCR cells show significantly decreased RIPK1-dependent apoptosis in acute scenarios compared to chronic ones, unlike the CO group, implying varied responses to different inflammatory stresses. In non-viable cells, considerable changes in RIPK1-dependent apoptosis under chronic conditions in HSCR indicate a heightened inflammatory response compared to CO.</p><p><strong>Conclusion: </strong>This research provides insights into cell death regulation in HSCR under inflammatory stress by using patient-derived organoids, underscoring the complexity of its inflammatory response.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"288"},"PeriodicalIF":1.5,"publicationDate":"2024-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promoting application of enhanced recovery after surgery protocols during perioperative localized abdominal and thoracic neuroblastomas. 在局部腹腔和胸腔神经母细胞瘤围手术期推广应用术后恢复强化方案。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-11-02 DOI: 10.1007/s00383-024-05884-w
Jingjing He, Zhiru Wang, Xiyang Yu, Yilin Su, Mingyun Hong, Kai Zhu
<p><strong>Aim: </strong>To investigate the safety and efficacy of the application of enhanced recovery after surgery (ERAS) protocols in the perioperative period of abdominal and thoracic localized neuroblastomas (NBs).</p><p><strong>Methods: </strong>In this retrospective study, 68 children with NBs who underwent surgical resection of the tumor were enrolled. The ERAS protocols for NB excision were implemented in the ERAS group (n = 39) and the consequences were compared with children treated with traditional care (n = 29, TRAD group). The main outcomes of our interest included the incidence of surgery-related complications, the postoperative length of stay (LOS), and the Face/Legs/Activity/Cry/Consolability (FLACC) quantitative table from postoperative days (POD) 1-5. We also evaluated the median intraoperative fluid volume and anesthesia recovery time; blood glucose levels at the beginning of anesthesia, POD1, and 3; WBC counts, CRP values, and the concentration of plasma nutritional indicators on POD1 and 3; time of early ambulation, first anal exhaust, total enteral nutrition (TEN), and discontinue intravenous infusion postoperatively; usage proportion and duration of abdominal and thoracic drainages, nasogastric decompression tubes and urinary catheters; cost of hospitalization, parental satisfaction rate, and readmission rate of surgery ward within 30 days.</p><p><strong>Results: </strong>Compared to the TRAD group, the ERAS group had lower surgery-related complications, albeit not significantly (P > 0.05); the median postoperative LOS decreased from 11.0 to 8.0 days (P < 0.001), the LOS of abdominal NB was significantly shortened (P < 0.001) compared to thoracic NB (P = 0.07) between the two groups; the FLACC scores decreased significantly from POD1-5 (all P < 0.01). The ERAS group had an improved median intraoperative infusion speed (5.0 mL/kg/h vs 8.0 mL/kg/h), time of early ambulation (1.0 days vs 3.0 days), first anal exhaust (2.0 days vs 2.0 days), TEN (5.0 vs 7.0 days), discontinuation of intravenous infusion (5.0 days vs 8.0 days), and total cost of hospitalization (33,897.2 Yuan vs 38,876.3 Yuan); (all P < 0.01). The usage proportion and duration of surgical drainages and tubes were apparently reduced. The mean blood glucose level was higher at the beginning of anesthesia but lower on POD1 and 3 in the ERAS group (P < 0.01). No statistically significant difference was detected in WBC counts and concentrations of hemoglobin and albumin between the two groups of patients (P > 0.05), while the concentrations of prealbumin on POD3 were higher and the CRP level on POD1 was lower in the ERAS group than the TRAD group (P < 0.01). The satisfaction rate of parents was only slightly higher, but the difference was not statistically significant (P = 0.730). No obvious differences were observed in the aspects of NB resection (P = 0.462) and 30-day readmissions of surgery ward (P = 1.000).</p><p><strong>Conclusion: </strong>The application of
目的:探讨在腹腔和胸腔局部神经母细胞瘤(NBs)围手术期应用增强术后恢复(ERAS)方案的安全性和有效性:在这项回顾性研究中,共纳入了68名接受肿瘤手术切除的NB患儿。ERAS组(39人)采用ERAS方案进行NB切除术,其结果与接受传统治疗的患儿(29人,TRAD组)进行了比较。我们关注的主要结果包括手术相关并发症的发生率、术后住院时间(LOS)以及术后第 1-5 天(POD)的面部/腿部/活动/哭泣/可溶性(FLACC)量化表。我们还评估了术中液体量和麻醉恢复时间的中位数;麻醉开始时、POD1 和 3 的血糖水平;POD1 和 3 的白细胞计数、CRP 值和血浆营养指标的浓度;术后早期下床活动、首次肛门排气、全肠内营养(TEN)和停止静脉输液的时间;腹腔和胸腔引流管、鼻胃减压管和导尿管的使用比例和持续时间;住院费用、家长满意率和 30 天内再次入住手术病房的比率。结果:与 TRAD 组相比,ERAS 组的手术相关并发症较低,但不明显(P > 0.05);术后 LOS 中位数从 11.0 天降至 8.0 天(P 0.05),而 ERAS 组 POD3 的前白蛋白浓度较 TRAD 组高,POD1 的 CRP 水平较 TRAD 组低(P 结论:与 TRAD 组相比,ERAS 组的手术相关并发症较低,但不明显(P > 0.05):ERAS方案的应用在加速腹部和胸部NB手术切除患儿围手术期康复方面具有显著潜力。
{"title":"Promoting application of enhanced recovery after surgery protocols during perioperative localized abdominal and thoracic neuroblastomas.","authors":"Jingjing He, Zhiru Wang, Xiyang Yu, Yilin Su, Mingyun Hong, Kai Zhu","doi":"10.1007/s00383-024-05884-w","DOIUrl":"https://doi.org/10.1007/s00383-024-05884-w","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To investigate the safety and efficacy of the application of enhanced recovery after surgery (ERAS) protocols in the perioperative period of abdominal and thoracic localized neuroblastomas (NBs).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In this retrospective study, 68 children with NBs who underwent surgical resection of the tumor were enrolled. The ERAS protocols for NB excision were implemented in the ERAS group (n = 39) and the consequences were compared with children treated with traditional care (n = 29, TRAD group). The main outcomes of our interest included the incidence of surgery-related complications, the postoperative length of stay (LOS), and the Face/Legs/Activity/Cry/Consolability (FLACC) quantitative table from postoperative days (POD) 1-5. We also evaluated the median intraoperative fluid volume and anesthesia recovery time; blood glucose levels at the beginning of anesthesia, POD1, and 3; WBC counts, CRP values, and the concentration of plasma nutritional indicators on POD1 and 3; time of early ambulation, first anal exhaust, total enteral nutrition (TEN), and discontinue intravenous infusion postoperatively; usage proportion and duration of abdominal and thoracic drainages, nasogastric decompression tubes and urinary catheters; cost of hospitalization, parental satisfaction rate, and readmission rate of surgery ward within 30 days.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Compared to the TRAD group, the ERAS group had lower surgery-related complications, albeit not significantly (P &gt; 0.05); the median postoperative LOS decreased from 11.0 to 8.0 days (P &lt; 0.001), the LOS of abdominal NB was significantly shortened (P &lt; 0.001) compared to thoracic NB (P = 0.07) between the two groups; the FLACC scores decreased significantly from POD1-5 (all P &lt; 0.01). The ERAS group had an improved median intraoperative infusion speed (5.0 mL/kg/h vs 8.0 mL/kg/h), time of early ambulation (1.0 days vs 3.0 days), first anal exhaust (2.0 days vs 2.0 days), TEN (5.0 vs 7.0 days), discontinuation of intravenous infusion (5.0 days vs 8.0 days), and total cost of hospitalization (33,897.2 Yuan vs 38,876.3 Yuan); (all P &lt; 0.01). The usage proportion and duration of surgical drainages and tubes were apparently reduced. The mean blood glucose level was higher at the beginning of anesthesia but lower on POD1 and 3 in the ERAS group (P &lt; 0.01). No statistically significant difference was detected in WBC counts and concentrations of hemoglobin and albumin between the two groups of patients (P &gt; 0.05), while the concentrations of prealbumin on POD3 were higher and the CRP level on POD1 was lower in the ERAS group than the TRAD group (P &lt; 0.01). The satisfaction rate of parents was only slightly higher, but the difference was not statistically significant (P = 0.730). No obvious differences were observed in the aspects of NB resection (P = 0.462) and 30-day readmissions of surgery ward (P = 1.000).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The application of ","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"286"},"PeriodicalIF":1.5,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends and outcomes in pediatric laparoscopic appendectomy: a NSQIP-P analysis of same-day discharge and readmission rates. 小儿腹腔镜阑尾切除术的趋势和结果:NSQIP-P 对当天出院率和再入院率的分析。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-11-02 DOI: 10.1007/s00383-024-05869-9
John M Woodward, Stephanie F Brierley, Krystle Bittner, Katherine Foote, Hector Osei, Carroll M Harmon, P Benson Ham Iii

Purpose: Practice patterns of same-day discharge for pediatric laparoscopic appendectomy for non-perforated appendicitis are not well-analyzed. Our aim is to evaluate current practice patterns and outcomes of same-day discharge for these patients.

Methods: NSQIP-P retrospective registry identified patients (2017-2021) who underwent laparoscopic appendectomy for non-perforated appendicitis. Annual same-day discharge (SDD) rate was determined. SDD patients were compared to those discharged postoperative days 1-2 (non-SDD). Sub-group analysis was performed on ICD-10 code K35.30. Regression was performed.

Results: Overall, 67,214 patients were identified. The SDD rate increased from 33.3% (2017) to 52.5% (2021) with decreased 30-day readmissions between SDD and non-SDD (1.3% vs 2.1%, p < 0.001). Sub-group analysis identified 7,330 patients with SDD rates from 50.7% (2019) to 60.4% (2021) with decreased 30-day readmissions (1.3% vs 2.1%, p < 0.001) for SDD versus non-SDD. No increase in adverse events for SDD occurred in either analysis. Regression identified esophageal/gastric/intestinal diseases increased odds of early readmission or reoperation (OR 1.85, p = 0.042).

Conclusion: Same-day discharge after pediatric laparoscopic appendectomy for non-perforated acute appendicitis continues to increase in frequency without a significant increase in adverse outcomes. SDD rates are 20-30% lower than previously published single-center studies, indicating there is a likely a larger percentage of patients that could discharge same-day.

Level of evidence (i-v): Level III.

目的:小儿腹腔镜阑尾切除术治疗非穿孔性阑尾炎的当日出院实践模式尚未得到充分分析。我们的目的是评估目前这些患者当天出院的实践模式和结果:NSQIP-P回顾性登记册确定了(2017-2021年)接受腹腔镜阑尾切除术治疗非穿孔性阑尾炎的患者。确定了年度当日出院率(SDD)。将 SDD 患者与术后第 1-2 天出院的患者(非 SDD)进行比较。根据 ICD-10 代码 K35.30 进行分组分析。结果:结果:共发现 67,214 名患者。SDD率从33.3%(2017年)上升至52.5%(2021年),SDD与非SDD的30天再入院率有所下降(1.3% vs 2.1%,P 结论:SDD率从33.3%(2017年)上升至52.5%(2021年),SDD与非SDD的30天再入院率有所下降:小儿腹腔镜阑尾切除术治疗非穿孔性急性阑尾炎后当天出院的频率继续增加,但不良后果并未显著增加。SDD率比之前发表的单中心研究低20%-30%,表明可能有更大比例的患者可以当天出院:III级。
{"title":"Trends and outcomes in pediatric laparoscopic appendectomy: a NSQIP-P analysis of same-day discharge and readmission rates.","authors":"John M Woodward, Stephanie F Brierley, Krystle Bittner, Katherine Foote, Hector Osei, Carroll M Harmon, P Benson Ham Iii","doi":"10.1007/s00383-024-05869-9","DOIUrl":"https://doi.org/10.1007/s00383-024-05869-9","url":null,"abstract":"<p><strong>Purpose: </strong>Practice patterns of same-day discharge for pediatric laparoscopic appendectomy for non-perforated appendicitis are not well-analyzed. Our aim is to evaluate current practice patterns and outcomes of same-day discharge for these patients.</p><p><strong>Methods: </strong>NSQIP-P retrospective registry identified patients (2017-2021) who underwent laparoscopic appendectomy for non-perforated appendicitis. Annual same-day discharge (SDD) rate was determined. SDD patients were compared to those discharged postoperative days 1-2 (non-SDD). Sub-group analysis was performed on ICD-10 code K35.30. Regression was performed.</p><p><strong>Results: </strong>Overall, 67,214 patients were identified. The SDD rate increased from 33.3% (2017) to 52.5% (2021) with decreased 30-day readmissions between SDD and non-SDD (1.3% vs 2.1%, p < 0.001). Sub-group analysis identified 7,330 patients with SDD rates from 50.7% (2019) to 60.4% (2021) with decreased 30-day readmissions (1.3% vs 2.1%, p < 0.001) for SDD versus non-SDD. No increase in adverse events for SDD occurred in either analysis. Regression identified esophageal/gastric/intestinal diseases increased odds of early readmission or reoperation (OR 1.85, p = 0.042).</p><p><strong>Conclusion: </strong>Same-day discharge after pediatric laparoscopic appendectomy for non-perforated acute appendicitis continues to increase in frequency without a significant increase in adverse outcomes. SDD rates are 20-30% lower than previously published single-center studies, indicating there is a likely a larger percentage of patients that could discharge same-day.</p><p><strong>Level of evidence (i-v): </strong>Level III.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"287"},"PeriodicalIF":1.5,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective analysis of alimentary tract duplications in pediatric patients: a 14-year single-center experience. 儿科患者消化道重复的回顾性分析:14 年的单中心经验。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-11-01 DOI: 10.1007/s00383-024-05881-z
Francesca Destro, Michela Marinaro, Eleonora Durante, Carlotta Ardenghi, Claudia Filisetti, Marcello Napolitano, Marta Barisella, Alessandro Pellegrinelli, Claudio Vella, Gabrio Bassotti, Gloria Pelizzo

Purpose: Alimentary tract duplications (ATDs) are rare congenital lesions often associated with anomalies such as spinal, urinary and GI tract malformations. The purpose of this study was to report the experience of a single center with ATDs in children, focusing on the natural history, associated malformations, and their impact on patient management.

Methods: We performed a retrospective analysis over 14 years, collecting prenatal, clinical, surgical, and follow-up data. We focus on associated anomalies prenatal and postnatal management, and outcomes.

Results: Sixty-three patients with ATD (thirty-six females, twenty-seven males, aged 1 day to 14 years) were enrolled in this study. Prenatal diagnosis was made in 22 patients (35%), of whom 8 showed compression signs. Elective surgery was performed at a mean age of 1.5 years in prenatally diagnosed cases. The others presented symptoms at a mean age of 5.2 years (55.5%) or were detected incidentally (9.5%) at a mean age of 10.7 years. In four patients (6.3%), we identified multiple duplications, and ten cases (15.8%) were found with associated anomalies.

Conclusion: The wide spectrum of clinical appearance of ATDs and a comprehensive knowledge of human embryology might define surgical management, which should always be patient-tailored and respectful of the child's development.

目的:消化道重复(ATD)是一种罕见的先天性病变,常伴有脊柱、泌尿道和消化道畸形等异常。本研究的目的是报告一个中心在儿童 ATD 方面的经验,重点是自然病史、相关畸形及其对患者管理的影响:我们对 14 年来的情况进行了回顾性分析,收集了产前、临床、手术和随访数据。我们重点研究了相关畸形的产前和产后处理以及结果:本研究共收录了 63 名 ATD 患者(36 名女性,27 名男性,年龄在 1 天至 14 岁之间)。22名患者(35%)获得产前诊断,其中8名患者出现压迫症状。产前诊断病例在平均 1.5 岁时接受了择期手术。其他患者在平均 5.2 岁(55.5%)时出现症状,或在平均 10.7 岁时偶然发现症状(9.5%)。在四例患者(6.3%)中,我们发现了多个重复,十例患者(15.8%)伴有异常:ATD的临床表现范围很广,对人类胚胎学的全面了解有助于确定手术治疗方法,手术治疗应始终以患者为中心,并尊重儿童的发育情况。
{"title":"A retrospective analysis of alimentary tract duplications in pediatric patients: a 14-year single-center experience.","authors":"Francesca Destro, Michela Marinaro, Eleonora Durante, Carlotta Ardenghi, Claudia Filisetti, Marcello Napolitano, Marta Barisella, Alessandro Pellegrinelli, Claudio Vella, Gabrio Bassotti, Gloria Pelizzo","doi":"10.1007/s00383-024-05881-z","DOIUrl":"https://doi.org/10.1007/s00383-024-05881-z","url":null,"abstract":"<p><strong>Purpose: </strong>Alimentary tract duplications (ATDs) are rare congenital lesions often associated with anomalies such as spinal, urinary and GI tract malformations. The purpose of this study was to report the experience of a single center with ATDs in children, focusing on the natural history, associated malformations, and their impact on patient management.</p><p><strong>Methods: </strong>We performed a retrospective analysis over 14 years, collecting prenatal, clinical, surgical, and follow-up data. We focus on associated anomalies prenatal and postnatal management, and outcomes.</p><p><strong>Results: </strong>Sixty-three patients with ATD (thirty-six females, twenty-seven males, aged 1 day to 14 years) were enrolled in this study. Prenatal diagnosis was made in 22 patients (35%), of whom 8 showed compression signs. Elective surgery was performed at a mean age of 1.5 years in prenatally diagnosed cases. The others presented symptoms at a mean age of 5.2 years (55.5%) or were detected incidentally (9.5%) at a mean age of 10.7 years. In four patients (6.3%), we identified multiple duplications, and ten cases (15.8%) were found with associated anomalies.</p><p><strong>Conclusion: </strong>The wide spectrum of clinical appearance of ATDs and a comprehensive knowledge of human embryology might define surgical management, which should always be patient-tailored and respectful of the child's development.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"283"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142562907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated laparoscopic extra-vesical ureteric reimplantation (I-LEVUR) for upper moiety ectopic ureter without lower moiety vesicoureteric reflux. 针对上段异位输尿管且无下段膀胱输尿管反流的孤立腹腔镜膀胱外输尿管再植术(I-LEVUR)。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-11-01 DOI: 10.1007/s00383-024-05876-w
Vikesh Agrawal, Ramesh Babu

Purpose: To evaluate the feasibility and outcomes of isolated laparoscopic extra-vesical ureteric reimplantation (I-LEVUR) for upper moiety ectopic ureter in patients with non-refluxing lower moiety ureter and avoid reimplanting normal lower moiety orifice.

Methods: Between 2013 and 2024, 12 patients (8 females, 4 males) with ectopic ureter associated with a duplex system underwent I-LEVUR. Preoperative assessment included ultrasonography, voiding cystourethrography (VCUG), and magnetic resonance urography (MRU)/retrograde pyelogram (RGP). The procedure involved laparoscopic extravesical approach dissecting only the ectopic ureter in lower most part, preserving vascularity, and performing an isolated reimplantation without manipulating lower moiety ureter.

Results: Twelve patients, with a median age of 2.8 years, underwent I-LEVUR. The mean operative time was 127.5 min. No intraoperative complications occurred. Postoperative follow-up (median: 78.5 months) showed no cases of ureteral obstruction or significant complications. Urinary continence improved in all patients. Two patients developed mild vesicoureteral reflux, managed conservatively, and one patient had minor urine leak which resolved spontaneously.

Conclusion: I-LEVUR is a viable and effective alternative to traditional en bloc reimplantation for upper moiety ectopic ureter. It preserves the normal ureteric orifice, reduces surgical trauma, and offers excellent outcomes in terms of renal function and urinary continence. Further studies with larger cohorts, control group of common sheath reimplantation, randomization, robust statistical validation and longer follow-up are recommended.

目的:评估孤立腹腔镜下输尿管外再植术(I-LEVUR)治疗下段输尿管无反流的上段异位输尿管的可行性和效果,避免再植正常的下段输尿管口:2013年至2024年期间,12例(8女4男)输尿管异位患者接受了I-LEVUR手术。术前评估包括超声波检查、排尿膀胱尿道造影(VCUG)和磁共振尿路造影(MRU)/逆行肾盂造影(RGP)。手术采用腹腔镜膀胱外入路,仅解剖异位输尿管的最下端,保留血管,在不操作下段输尿管的情况下进行孤立再植:12 名患者接受了 I-LEVUR 手术,中位年龄为 2.8 岁。平均手术时间为 127.5 分钟。术中未出现并发症。术后随访(中位数:78.5 个月)显示无输尿管梗阻或重大并发症。所有患者的尿失禁情况都有所改善。两名患者出现了轻微的膀胱输尿管反流,保守治疗,一名患者出现轻微漏尿,但已自行缓解:结论:对于上段异位输尿管,I-LEVUR 是替代传统的整体再植术的一种可行而有效的方法。结论:I-LEVUR 是治疗上段异位输尿管的一种可行、有效的替代方法,它保留了正常的输尿管口,减少了手术创伤,在肾功能和排尿功能方面都有很好的疗效。建议进行更大规模的研究,以普通鞘管再植术为对照组,采用随机方法,进行可靠的统计验证,并进行更长时间的随访。
{"title":"Isolated laparoscopic extra-vesical ureteric reimplantation (I-LEVUR) for upper moiety ectopic ureter without lower moiety vesicoureteric reflux.","authors":"Vikesh Agrawal, Ramesh Babu","doi":"10.1007/s00383-024-05876-w","DOIUrl":"https://doi.org/10.1007/s00383-024-05876-w","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the feasibility and outcomes of isolated laparoscopic extra-vesical ureteric reimplantation (I-LEVUR) for upper moiety ectopic ureter in patients with non-refluxing lower moiety ureter and avoid reimplanting normal lower moiety orifice.</p><p><strong>Methods: </strong>Between 2013 and 2024, 12 patients (8 females, 4 males) with ectopic ureter associated with a duplex system underwent I-LEVUR. Preoperative assessment included ultrasonography, voiding cystourethrography (VCUG), and magnetic resonance urography (MRU)/retrograde pyelogram (RGP). The procedure involved laparoscopic extravesical approach dissecting only the ectopic ureter in lower most part, preserving vascularity, and performing an isolated reimplantation without manipulating lower moiety ureter.</p><p><strong>Results: </strong>Twelve patients, with a median age of 2.8 years, underwent I-LEVUR. The mean operative time was 127.5 min. No intraoperative complications occurred. Postoperative follow-up (median: 78.5 months) showed no cases of ureteral obstruction or significant complications. Urinary continence improved in all patients. Two patients developed mild vesicoureteral reflux, managed conservatively, and one patient had minor urine leak which resolved spontaneously.</p><p><strong>Conclusion: </strong>I-LEVUR is a viable and effective alternative to traditional en bloc reimplantation for upper moiety ectopic ureter. It preserves the normal ureteric orifice, reduces surgical trauma, and offers excellent outcomes in terms of renal function and urinary continence. Further studies with larger cohorts, control group of common sheath reimplantation, randomization, robust statistical validation and longer follow-up are recommended.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"284"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142562908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival rate changes in children with congenital diaphragmatic hernia over the past three decades: a nationwide, population-based prospective nested case-control study. 过去三十年先天性膈疝患儿存活率的变化:一项全国性、基于人群的前瞻性巢式病例对照研究。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-11-01 DOI: 10.1007/s00383-024-05860-4
B Kutasy, C M Burgos

Purpose: The survival rate (SR) for neonates born with congenital diaphragmatic hernia (CDH) remains high. Our aim was to investigate the change in SR in children with CDH over the past decades.

Methods: The study was a nationwide, population-based prospective nested case-control study within a cohort of newborn children who was born in Sweden during the observational period from 1st January 1982 to 31st December 2015.

Results: In the study period, 4654 (99.6%) control children and 684 children with CDH (70.4%, p < 0.001) were with a survival of 2 years of age. Any patients who were born with CDH had a overall 5.8 times higher chance for not surviving 2 years of age than children without CDH. The SR improved significantly in CDH in the past 3 decades. Significantly higher number of patients were prematurely born in the CDH group than in the controls (23.3 vs 6.1%, p < 0.001). The SR of premature and non-premature born CDH patients has increased significantly over the past 3 decades.

Conclusion: The SR of CDH patients were significantly increased in the past 3 decades. The 2-year survival remains 5.8 times higher than those who were not born with CDH. These changes were mainly attributed to the improved SR of premature and non-premature born CDH patients.

目的:患有先天性膈疝(CDH)的新生儿存活率(SR)仍然很高。我们的目的是调查过去几十年来 CDH 患儿存活率的变化情况:该研究是一项全国性、基于人口的前瞻性巢式病例对照研究,研究对象是1982年1月1日至2015年12月31日期间在瑞典出生的新生儿队列:在研究期间,4654名(99.6%)对照组儿童和684名CDH儿童(70.4%,P 结论:CDH患者的SR显著高于对照组儿童:CDH患者的SR在过去30年中明显增加。2年存活率仍比非 CDH 患儿高出 5.8 倍。这些变化主要归因于早产和非早产 CDH 患者的 SR 有所提高。
{"title":"Survival rate changes in children with congenital diaphragmatic hernia over the past three decades: a nationwide, population-based prospective nested case-control study.","authors":"B Kutasy, C M Burgos","doi":"10.1007/s00383-024-05860-4","DOIUrl":"https://doi.org/10.1007/s00383-024-05860-4","url":null,"abstract":"<p><strong>Purpose: </strong>The survival rate (SR) for neonates born with congenital diaphragmatic hernia (CDH) remains high. Our aim was to investigate the change in SR in children with CDH over the past decades.</p><p><strong>Methods: </strong>The study was a nationwide, population-based prospective nested case-control study within a cohort of newborn children who was born in Sweden during the observational period from 1st January 1982 to 31st December 2015.</p><p><strong>Results: </strong>In the study period, 4654 (99.6%) control children and 684 children with CDH (70.4%, p < 0.001) were with a survival of 2 years of age. Any patients who were born with CDH had a overall 5.8 times higher chance for not surviving 2 years of age than children without CDH. The SR improved significantly in CDH in the past 3 decades. Significantly higher number of patients were prematurely born in the CDH group than in the controls (23.3 vs 6.1%, p < 0.001). The SR of premature and non-premature born CDH patients has increased significantly over the past 3 decades.</p><p><strong>Conclusion: </strong>The SR of CDH patients were significantly increased in the past 3 decades. The 2-year survival remains 5.8 times higher than those who were not born with CDH. These changes were mainly attributed to the improved SR of premature and non-premature born CDH patients.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"285"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142562909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of partial versus total splenectomy in the treatment of hereditary spherocytosis in children: a systematic review and meta-analysis. 治疗儿童遗传性球形红细胞增多症的部分脾切除术与全脾切除术的疗效:系统综述和荟萃分析。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-10-29 DOI: 10.1007/s00383-024-05879-7
Xilong Tang, Jianjin Xue, Jie Zhang, Jiajia Zhou

Objective: To explore the comparative postoperative efficacy of partial splenectomy (PS) and total splenectomy (TS) in the treatment of children with hereditary spherocytosis (HS).

Methods: The relevant HS studies from databases were searched and screened, comparing the differences in hemoglobin concentration, reticulocyte percentage, bilirubin concentration before and after TS and PS surgery, and during the follow-up period, as well as the incidence of postoperative adverse events. Statistical analysis was performed using Review Manager 5.4.

Results: A total of 5 studies were included in this meta-analysis, with a cumulative enrollment of 312 children, 130 in the PS group and 182 in the TS group. The meta-analysis results showed that both PS and TS groups had statistically significant differences in postoperative hematological outcomes compared to before surgery, with TS showing better improvement than PS. In the postoperative follow-up, the changes in hematological outcomes between PS and TS were statistically significant for hemoglobin concentration: within 1 year [MD = 1.85, 95%CI(1.09,2.60)], 1-2 years [MD = 1.74, 95%CI(0.25,3.24)], not statistically significant for 4-6 years [MD = 1.28, 95%CI(-1.75,4.32)]; for reticulocyte percentage: within 1 year [MD = 2.23, 95%CI(0.80,3.66)] was statistically significant, not statistically significant for 4-6 years [MD = 1.77, 95%CI(-2.04,5.59)]; for serum bilirubin concentration: within 1 year [MD = 1.55, 95%CI(0.91,2.18)] was statistically significant, not statistically significant for 1-2 years [MD = 1.77, 95%CI(-2.04,5.99)]. In the incidence of postoperative adverse events, the incidence of cholelithiasis [MD = 1.77, 95%CI(-2.04,5.99)] showed a statistically significant difference between PS and TS, while there were no statistically significant differences in other included events, such as postoperative infection rate, secondary surgery rate, thrombosis rate, postoperative hemorrhage rate, and transfusion therapy rate.

Conclusion: Splenectomy is a beneficial surgical strategy for children with moderate-to-severe HS, reducing; early hematological outcomes of TS are more robust than PS in the follow-up period, and there is no difference between the two in the later period; for postoperative adverse events, the incidence of cholelithiasis in children after PS is higher than after TS, and there is a risk of requiring a second surgery for total splenectomy due to hemolytic recurrences.

目的探讨脾部分切除术(PS)和全脾切除术(TS)治疗遗传性球形红细胞增多症(HS)患儿的术后疗效比较:方法:检索并筛选数据库中相关的 HS 研究,比较 TS 和 PS 手术前后和随访期间血红蛋白浓度、网状细胞百分比、胆红素浓度的差异,以及术后不良反应的发生率。统计分析使用Review Manager 5.4进行:本次荟萃分析共纳入了 5 项研究,累计入选患儿 312 名,其中 PS 组 130 名,TS 组 182 名。荟萃分析结果显示,PS组和TS组的术后血液学结果与术前相比均有显著统计学差异,其中TS组的改善效果优于PS组。在术后随访中,PS组和TS组血液学结果的变化在血红蛋白浓度方面有统计学意义:1年内[MD = 1.85,95%CI(1.09,2.60)],1-2年内[MD = 1.74,95%CI(0.25,3.24)],4-6年内[MD = 1.28,95%CI(-1.75,4.32)]无统计学意义;网织红细胞百分比方面:1年内[MD = 2.23,95%CI(0.80,3.66)]有统计学意义,4-6 年[MD = 1.77,95%CI(-2.04,5.59)]无统计学意义;血清胆红素浓度:1 年内[MD = 1.55,95%CI(0.91,2.18)]有统计学意义,1-2 年[MD = 1.77,95%CI(-2.04,5.99)]无统计学意义。在术后不良事件的发生率方面,PS和TS的胆石症发生率[MD = 1.77,95%CI(-2.04,5.99)]差异有统计学意义,而术后感染率、二次手术率、血栓形成率、术后出血率和输血治疗率等其他不良事件的发生率差异无统计学意义:结论:脾切除术是一种有益于中重度HS患儿的手术策略,可减少;在随访期间,TS的早期血液学结果比PS更稳健,二者在后期没有差异;在术后不良事件方面,PS术后患儿胆石症的发生率高于TS术后,且存在因溶血复发而需要二次手术进行全脾切除的风险。
{"title":"The efficacy of partial versus total splenectomy in the treatment of hereditary spherocytosis in children: a systematic review and meta-analysis.","authors":"Xilong Tang, Jianjin Xue, Jie Zhang, Jiajia Zhou","doi":"10.1007/s00383-024-05879-7","DOIUrl":"10.1007/s00383-024-05879-7","url":null,"abstract":"<p><strong>Objective: </strong>To explore the comparative postoperative efficacy of partial splenectomy (PS) and total splenectomy (TS) in the treatment of children with hereditary spherocytosis (HS).</p><p><strong>Methods: </strong>The relevant HS studies from databases were searched and screened, comparing the differences in hemoglobin concentration, reticulocyte percentage, bilirubin concentration before and after TS and PS surgery, and during the follow-up period, as well as the incidence of postoperative adverse events. Statistical analysis was performed using Review Manager 5.4.</p><p><strong>Results: </strong>A total of 5 studies were included in this meta-analysis, with a cumulative enrollment of 312 children, 130 in the PS group and 182 in the TS group. The meta-analysis results showed that both PS and TS groups had statistically significant differences in postoperative hematological outcomes compared to before surgery, with TS showing better improvement than PS. In the postoperative follow-up, the changes in hematological outcomes between PS and TS were statistically significant for hemoglobin concentration: within 1 year [MD = 1.85, 95%CI(1.09,2.60)], 1-2 years [MD = 1.74, 95%CI(0.25,3.24)], not statistically significant for 4-6 years [MD = 1.28, 95%CI(-1.75,4.32)]; for reticulocyte percentage: within 1 year [MD = 2.23, 95%CI(0.80,3.66)] was statistically significant, not statistically significant for 4-6 years [MD = 1.77, 95%CI(-2.04,5.59)]; for serum bilirubin concentration: within 1 year [MD = 1.55, 95%CI(0.91,2.18)] was statistically significant, not statistically significant for 1-2 years [MD = 1.77, 95%CI(-2.04,5.99)]. In the incidence of postoperative adverse events, the incidence of cholelithiasis [MD = 1.77, 95%CI(-2.04,5.99)] showed a statistically significant difference between PS and TS, while there were no statistically significant differences in other included events, such as postoperative infection rate, secondary surgery rate, thrombosis rate, postoperative hemorrhage rate, and transfusion therapy rate.</p><p><strong>Conclusion: </strong>Splenectomy is a beneficial surgical strategy for children with moderate-to-severe HS, reducing; early hematological outcomes of TS are more robust than PS in the follow-up period, and there is no difference between the two in the later period; for postoperative adverse events, the incidence of cholelithiasis in children after PS is higher than after TS, and there is a risk of requiring a second surgery for total splenectomy due to hemolytic recurrences.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"280"},"PeriodicalIF":1.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of lateral-anteroposterior dimeter ratio in patients with tracheomalacia associated with esophageal atresia. 食管闭锁伴气管异位症患者的侧位-前后位二维比值的实用性。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-10-29 DOI: 10.1007/s00383-024-05877-9
Wataru Sumida, Takahisa Tainaka, Chiyoe Shirota, Satoshi Makita, Hizuru Amano, Akihiro Yasui, Takuya Maeda, Daiki Kato, Yosuke Goda, Hiroki Ishii, Kazuki Ota, Guo Yaohui, Liu Jiahui, Akinari Hinoki, Hiroo Uchida

Purpose: Tracheomalacia (TM) is commonly associated with esophageal atresia (EA) and compression by the brachiocephalic artery is a factor for TM. Previous research has focused on the lateral-to-anteroposterior tracheal diameter ratio (LAR). This study aimed to assess the LAR and postoperative outcomes of EA patients.

Methods: Patients undergoing thoracoscopic repair for EA between March 2020 and October 2023 were enrolled. Posterior tracheopexy (PT) was performed during thoracoscopic repair of EA on patients with bronchoscopy-confirmed TM; clinical courses and LAR were retrospectively analyzed.

Results: Overall, 18 patients were enrolled; 14 patients underwent PT. Their median preoperative and postoperative LARs were 2.26 and 1.50, respectively; this difference was statistically significant. Four patients without TM did not undergo PT and their median LAR was 1.59. Median LAR for patients without PT was lower than that of preoperative patients with PT and no statistical differences were observed from that of postoperative patients with PT. The patients whose LAR improved with PT did not require further surgical intervention for TM. One patient who had a postoperative LAR of 2.25 required external tracheal stenting.

Conclusion: LAR is a useful index for determining the severity of TM associated with EA. LAR can reflects the efficacy of PT.

目的:气管畸形(TM)通常与食管闭锁(EA)有关,肱动脉的压迫是导致气管畸形的一个因素。以往的研究主要集中在气管外侧与前胸直径比值(LAR)上。本研究旨在评估 LAR 和 EA 患者的术后效果:纳入2020年3月至2023年10月期间接受胸腔镜修复术治疗EA的患者。在胸腔镜下修复 EA 期间,对支气管镜确诊为 TM 的患者进行了后气管切开术(PT);对临床病程和 LAR 进行了回顾性分析:共有 18 名患者入选,其中 14 名患者接受了气管插管术。他们术前和术后的 LAR 中位数分别为 2.26 和 1.50,差异具有统计学意义。4 名没有 TM 的患者没有进行 PT,他们的中位 LAR 为 1.59。未进行 PT 的患者的 LAR 中位数低于术前进行 PT 的患者,与术后进行 PT 的患者的 LAR 中位数相比无统计学差异。经 PT 治疗后 LAR 得到改善的患者不需要进一步的 TM 手术治疗。一名术后 LAR 为 2.25 的患者需要外置气管支架:结论:LAR 是判断与 EA 相关的 TM 严重程度的有用指标。结论:LAR 是判断 EA 相关 TM 严重程度的有用指标,LAR 可以反映 PT 的疗效。
{"title":"Usefulness of lateral-anteroposterior dimeter ratio in patients with tracheomalacia associated with esophageal atresia.","authors":"Wataru Sumida, Takahisa Tainaka, Chiyoe Shirota, Satoshi Makita, Hizuru Amano, Akihiro Yasui, Takuya Maeda, Daiki Kato, Yosuke Goda, Hiroki Ishii, Kazuki Ota, Guo Yaohui, Liu Jiahui, Akinari Hinoki, Hiroo Uchida","doi":"10.1007/s00383-024-05877-9","DOIUrl":"https://doi.org/10.1007/s00383-024-05877-9","url":null,"abstract":"<p><strong>Purpose: </strong>Tracheomalacia (TM) is commonly associated with esophageal atresia (EA) and compression by the brachiocephalic artery is a factor for TM. Previous research has focused on the lateral-to-anteroposterior tracheal diameter ratio (LAR). This study aimed to assess the LAR and postoperative outcomes of EA patients.</p><p><strong>Methods: </strong>Patients undergoing thoracoscopic repair for EA between March 2020 and October 2023 were enrolled. Posterior tracheopexy (PT) was performed during thoracoscopic repair of EA on patients with bronchoscopy-confirmed TM; clinical courses and LAR were retrospectively analyzed.</p><p><strong>Results: </strong>Overall, 18 patients were enrolled; 14 patients underwent PT. Their median preoperative and postoperative LARs were 2.26 and 1.50, respectively; this difference was statistically significant. Four patients without TM did not undergo PT and their median LAR was 1.59. Median LAR for patients without PT was lower than that of preoperative patients with PT and no statistical differences were observed from that of postoperative patients with PT. The patients whose LAR improved with PT did not require further surgical intervention for TM. One patient who had a postoperative LAR of 2.25 required external tracheal stenting.</p><p><strong>Conclusion: </strong>LAR is a useful index for determining the severity of TM associated with EA. LAR can reflects the efficacy of PT.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"282"},"PeriodicalIF":1.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dipeptidyl peptidase IV inhibitors reduce hepatic fibrosis and lipid accumulation in rat intestinal failure-associated liver disease models. 二肽基肽酶 IV 抑制剂可减轻大鼠肠功能衰竭相关肝病模型中的肝纤维化和脂质蓄积。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-10-29 DOI: 10.1007/s00383-024-05863-1
Ryo Sueyoshi, Junya Ishii, Susumu Yamada, Marumi Kawakami, Kenji Tanabe, Osamu Segawa

Purpose: This study aimed to investigate the effectiveness of dipeptidyl peptidase IV inhibitors (DPP4-I) against liver damage, especially fibrosis and lipid accumulation, in a rat intestinal failure-associated liver disease (IFALD) model.

Methods: SD rats were divided into two groups: the Control (n = 7; normal saline + IFALD model) and DPP4-I (n = 7; DPP4-I + IFALD model; short bowel syndrome (SBS) + total parenteral nutrition) groups. All rats were euthanized 21 days postoperatively to obtain tissue samples. Liver fibrosis was evaluated by Sirius Red and α-SMA staining. Liver damage was assessed using the steatosis, activity, and fibrosis score. Inflammation cytokines were examined by ELISA.

Results: The survival rate was comparatively different, being 87.5% in the DPP4-I group and 70.0% in the Control group. Two rats of the Control group showed progressive liver fibrosis in the periportal area with fibrous streaks. Further, the mean area percentage of α-SMA immune-positive cells was significantly lower in the DPP4-I group than in the Control group. TGF-β levels were significantly lower in the DPP4-I group than in the Control group.

Conclusion: DPP4-I administration reduced liver fibrosis in IFALD, possibly by inhibiting DPP4-I-induced adipogenesis and suppressing TGF-β. These results may contribute to elucidating the mechanism of IFALD.

目的:本研究旨在探讨二肽基肽酶IV抑制剂(DPP4-I)对大鼠肠功能衰竭相关肝病(IFALD)模型中肝脏损伤,尤其是肝纤维化和脂质蓄积的有效性:将 SD 大鼠分为两组:对照组(n = 7;正常生理盐水 + IFALD 模型)和 DPP4-I 组(n = 7;DPP4-I + IFALD 模型;短肠综合征 (SBS) + 全肠外营养)。所有大鼠在术后 21 天安乐死,以获取组织样本。肝纤维化通过天狼星红和α-SMA染色进行评估。肝脏损伤采用脂肪变性、活性和纤维化评分进行评估。用 ELISA 检测炎症细胞因子:DPP4-I组和对照组的存活率分别为87.5%和70.0%。对照组有两只大鼠的肝门周围区域出现进行性肝纤维化,并伴有纤维条纹。此外,DPP4-I 组 α-SMA 免疫阳性细胞的平均面积百分比明显低于对照组。DPP4-I组的TGF-β水平明显低于对照组:结论:服用DPP4-I可减轻IFALD患者的肝纤维化,这可能是通过抑制DPP4-I诱导的脂肪生成和抑制TGF-β实现的。这些结果可能有助于阐明 IFALD 的发病机制。
{"title":"Dipeptidyl peptidase IV inhibitors reduce hepatic fibrosis and lipid accumulation in rat intestinal failure-associated liver disease models.","authors":"Ryo Sueyoshi, Junya Ishii, Susumu Yamada, Marumi Kawakami, Kenji Tanabe, Osamu Segawa","doi":"10.1007/s00383-024-05863-1","DOIUrl":"https://doi.org/10.1007/s00383-024-05863-1","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the effectiveness of dipeptidyl peptidase IV inhibitors (DPP4-I) against liver damage, especially fibrosis and lipid accumulation, in a rat intestinal failure-associated liver disease (IFALD) model.</p><p><strong>Methods: </strong>SD rats were divided into two groups: the Control (n = 7; normal saline + IFALD model) and DPP4-I (n = 7; DPP4-I + IFALD model; short bowel syndrome (SBS) + total parenteral nutrition) groups. All rats were euthanized 21 days postoperatively to obtain tissue samples. Liver fibrosis was evaluated by Sirius Red and α-SMA staining. Liver damage was assessed using the steatosis, activity, and fibrosis score. Inflammation cytokines were examined by ELISA.</p><p><strong>Results: </strong>The survival rate was comparatively different, being 87.5% in the DPP4-I group and 70.0% in the Control group. Two rats of the Control group showed progressive liver fibrosis in the periportal area with fibrous streaks. Further, the mean area percentage of α-SMA immune-positive cells was significantly lower in the DPP4-I group than in the Control group. TGF-β levels were significantly lower in the DPP4-I group than in the Control group.</p><p><strong>Conclusion: </strong>DPP4-I administration reduced liver fibrosis in IFALD, possibly by inhibiting DPP4-I-induced adipogenesis and suppressing TGF-β. These results may contribute to elucidating the mechanism of IFALD.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"281"},"PeriodicalIF":1.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STAT trial: stoma or intestinal anastomosis for necrotizing enterocolitis: a multicentre randomized controlled trial. STAT试验:治疗坏死性小肠结肠炎的造口术还是肠吻合术:多中心随机对照试验。
IF 1.5 3区 医学 Q2 PEDIATRICS Pub Date : 2024-10-29 DOI: 10.1007/s00383-024-05853-3
Simon Eaton, Niloofar Ganji, Mandela Thyoka, Maher Shahroor, Augusto Zani, Hazel Pleasants-Terashita, Ali El Ghazzaoui, Jayaram Sivaraj, Stavros Loukogeorgakis, Paolo De Coppi, Sandra Montedonico, Sanja Sindjic-Antunovic, Marija Lukac, James Hamill, Candy Suet Cheng Choo, Shireen Anne Nah, Jan Hulscher, Sherif Emil, Aigars Petersen, Rene Wijnen, Cornelius Sloots, David Sigalet, Edward Kiely, Jan F Svensson, Tomas Wester, Agostino Pierro

Purpose: The STAT trial is a multicenter randomized controlled trial in 12 centers worldwide aiming to determine the most effective operation for neonates with necrotizing enterocolitis (NEC) requiring intestinal resection: stoma formation (ST) or primary anastomosis (PA).

Methods: Infants having a primary laparotomy for NEC were randomized intraoperatively to PA or ST if the operating surgeon thought that both were viable treatment options for that patient. The primary outcome (duration of parenteral nutrition [PN]) was evaluated by Cox regression.

Results: Eighty patients were recruited from 2010 to 2019. Infants undergoing anastomosis finished PN significantly earlier than patients undergoing stoma (hazard ratio PA vs. ST 2.38, 95% CI 1.36-4.12 p = 0.004). There was no difference in mortality between the two groups (PA 4/35 vs. ST 8/38 p = 0.35) or in the rate of complications requiring further unplanned operations (p = n.s.). Multiple intestinal complications were more frequent in the stoma group compared to the anastomosis group (ST 12/26 vs. PA 5/31, p = 0.02, Fisher's Exact test).

Conclusion: At laparotomy for NEC, when there is no disease distal to resected intestine, primary anastomosis should be performed as it enhances the recovery from NEC, reduces the risk of multiple intestinal complications and does not increase adverse outcomes.

目的:STAT 试验是一项在全球 12 个中心开展的多中心随机对照试验,旨在确定对需要进行肠道切除术的坏死性小肠结肠炎(NEC)新生儿最有效的手术方法:造口形成(ST)或原位吻合(PA):方法:因 NEC 而进行初次开腹手术的婴儿,如果手术医生认为 PA 或 ST 都是可行的治疗方案,则在术中随机选择 PA 或 ST。主要结果(肠外营养[PN]持续时间)通过 Cox 回归进行评估:从 2010 年到 2019 年,共招募了 80 名患者。接受吻合术的婴儿完成肠外营养的时间明显早于接受造口术的患者(危险比 PA vs. ST 2.38,95% CI 1.36-4.12 p = 0.004)。两组患者的死亡率无差异(PA 4/35 vs. ST 8/38 p = 0.35),需要进一步计划外手术的并发症发生率也无差异(p = n.s.)。与吻合组相比,造口组的多重肠道并发症发生率更高(ST 12/26 vs. PA 5/31,p = 0.02,费舍尔精确检验):结论:在对 NEC 进行开腹手术时,如果切除肠道的远端没有病变,则应进行初级吻合术,因为它能促进 NEC 的恢复,降低出现多种肠道并发症的风险,并且不会增加不良后果。
{"title":"STAT trial: stoma or intestinal anastomosis for necrotizing enterocolitis: a multicentre randomized controlled trial.","authors":"Simon Eaton, Niloofar Ganji, Mandela Thyoka, Maher Shahroor, Augusto Zani, Hazel Pleasants-Terashita, Ali El Ghazzaoui, Jayaram Sivaraj, Stavros Loukogeorgakis, Paolo De Coppi, Sandra Montedonico, Sanja Sindjic-Antunovic, Marija Lukac, James Hamill, Candy Suet Cheng Choo, Shireen Anne Nah, Jan Hulscher, Sherif Emil, Aigars Petersen, Rene Wijnen, Cornelius Sloots, David Sigalet, Edward Kiely, Jan F Svensson, Tomas Wester, Agostino Pierro","doi":"10.1007/s00383-024-05853-3","DOIUrl":"10.1007/s00383-024-05853-3","url":null,"abstract":"<p><strong>Purpose: </strong>The STAT trial is a multicenter randomized controlled trial in 12 centers worldwide aiming to determine the most effective operation for neonates with necrotizing enterocolitis (NEC) requiring intestinal resection: stoma formation (ST) or primary anastomosis (PA).</p><p><strong>Methods: </strong>Infants having a primary laparotomy for NEC were randomized intraoperatively to PA or ST if the operating surgeon thought that both were viable treatment options for that patient. The primary outcome (duration of parenteral nutrition [PN]) was evaluated by Cox regression.</p><p><strong>Results: </strong>Eighty patients were recruited from 2010 to 2019. Infants undergoing anastomosis finished PN significantly earlier than patients undergoing stoma (hazard ratio PA vs. ST 2.38, 95% CI 1.36-4.12 p = 0.004). There was no difference in mortality between the two groups (PA 4/35 vs. ST 8/38 p = 0.35) or in the rate of complications requiring further unplanned operations (p = n.s.). Multiple intestinal complications were more frequent in the stoma group compared to the anastomosis group (ST 12/26 vs. PA 5/31, p = 0.02, Fisher's Exact test).</p><p><strong>Conclusion: </strong>At laparotomy for NEC, when there is no disease distal to resected intestine, primary anastomosis should be performed as it enhances the recovery from NEC, reduces the risk of multiple intestinal complications and does not increase adverse outcomes.</p>","PeriodicalId":19832,"journal":{"name":"Pediatric Surgery International","volume":"40 1","pages":"279"},"PeriodicalIF":1.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142546726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Surgery International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1